The renal system is the most important regulator of the body's internal environment (
1). Chronic renal disease is a burden to society due to its high prevalence and treatment costs (
2). In western societies, the incidence of chronic kidney disease (CKD) is increasing so that approximately 10% of the population over the age of 20 are involved (
3). Diabetes is the main cause of CKD. Other causes include hypertension, pyelonephritis, nitrogen and blood urea disorders, glomerulonephritis, renal disease family history, maternal disorders, and kidney cancers (
1). In Iran, there were approximately 58,000 people with CKD up to the end of 2016 (
4). Depending on the cause of CKD, the available treatment options are different, including dialysis and kidney transplants (
2).
There are some limitations for patients with dialysis treatment options. They feel that they are dependent on other individuals and are insecure about their future. Other stressful factors for these patients are feeling of powerlessness, lack of control over the disease and its treatment, limitation imposed by medication, lack of self-confidence, financial burden, and sexual performance (
5).
Another option for these patients is kidney transplantation (
2). A kidney transplantation is a surgical procedure to place a healthy kidney from a living or deceased donor into a person whose kidneys no longer function properly and is considered as the desired treatment. Patients with kidney transplantation show higher QoL compared with patients under other treatments. Without the need for hemodialysis, recipients of a successful kidney transplant can live a normal life socially and vocationally. Although the cost during the first year after surgery is higher than the one-year cost of dialysis, the cost for transplant patients significantly decreases in the following years. Finally, the survival of dialysis patients has been widely improved, but transplantation can help them have longer lives (
6). In Iran, approximately 3,000 patients with CKD have kidney transplantation annually (
5). The three sources for kidney transplants are a family member as a living donor, a living donor for financial compensation or philanthropical reason, and a deceased donor (
2,
7).
Studies show an increasing trend in kidney transplants from a living donor in western societies (
8). About half of the kidney transplantations in developed countries (e.g., US and UK) are from living donors (
9). Since the number of kidney donations from deceased donors is not sufficient, and due to the constant increase in the kidney transplant waiting list, more attention has been paid to living donors recently (
10). Receiving a kidney from a family member increases the recipient’s life expectancy. The better outcomes of a transplant from a family member is attributed to minimum cold ischemia and similar human lymphocytes antigens. Moreover, when receiving kidney from a family member, the necessity for immunosuppressive diet decreases (
11,
12). Receiving kidney from a deceased donor can cause emotional disorder due to the false image of relating the donor’s death to the recipient’s survival. Recipients from deceased donors are usually from low-income families who cannot afford to receive kidney from a living donor. Since these patients have been on the waiting list for a long period of time, they are more prone to emotional disorders (
13).
In recent years, the QoL has been considered as a very important factor in health. Health and performance improvement has been considered as one of the important factors in patients with renal failure (
14). The QoL is a multi-dimensional concept that includes physical health, disease prognosis, and treatment, economic and social aspects of the patient's life that can be changed with time. (
15). In many studies, the QoL has been identified as a key factor after transplant (
16).
Another factor affected by kidney transplantation in recipients from living and deceased donors is the emotional response, which refers to a set of behaviors, reactions, and assumptions of the recipient toward the transplanted kidney; emotional response may include depression, anxiety, feeling guilty and responsible after the transplant surgery, anxiety about transplant disclosure, and medication compliance. Recipients may show different emotional responses depending on whether the kidney was received from a deceased, living, or relative donor. The patients’ response, such as feeling guilty and frustration can affect their QoL, performance, and behavior (
17). Kim et al. showed that kidney transplant can affect the recipients’ QoL and emotional responses (
18). Moreover, de Groot et al. showed that recipients who received kidney from a living donor had a better QoL, less performance degradation from a physical problem, higher social involvement, and a better overall health (
19). In addition, de Groot et al. found that kidney recipients from a deceased donor had a higher sense of responsibility for taking care of themselves. In 2016, Zimmerman et al. (
20) investigated the emotional response in terms of anxiety, medication compliance, transplant disclosure, and QoL among kidney recipients from deceased or living donors and did not report a significant difference between the two groups. However, recipients from a living donor felt guiltier and had a higher level of anxiety in comparison to kidney recipients from a deceased donor. Accordingly, this study aimed to identify the emotional response as an important factor in balancing emotional reactions after transplant surgery.
Thus, the emotional response of kidney recipients depends on whether they received the kidney from a living or deceased donor; as a result, this can impact their QoL.